AARDEX Group is dedicated to staying at the forefront of industry knowledge and expertise. That's why we regularly attend industry events and host webinars featuring top-tier experts in medication adherence. These webinars provide valuable insights and give attendees a front-row seat to the latest industry trends and developments.
LEARN WITH AARDEX GROUP
We are excited to offer on-demand and upcoming webinars focused on medication adherence. Our webinars feature industry-leading experts who provide actionable insights and strategies to improve medication adherence and ultimately, patient outcomes. Whether you are a healthcare provider, researcher, or patient, our webinars offer invaluable information and resources to help you better understand medication adherence and its importance in healthcare. Don't miss out on this opportunity to learn from the best in the field and stay up-to-date on the latest advancements in medication adherence. Register now for our upcoming webinars or access our on-demand webinars at any time.
Tamas Andras Koncz, MD, PhD, Chief Medical Officer, Accord CMO at Pfizer and EMEA President at the Medical Affairs Professional Society (MAPS); Jorge Cancela, PhD, Digital Health Leader at Roche; Antoine Pironet, PhD, Data Science Lead at AARDEX Group; Bernard Vrijens, PhD, Chief Executive Officer and Scientific Lead at AARDEX Group.
Rakhi Kilaru, Executive Director of Statistical Science at Thermo Fisher Scientific; Bruce Binkowitz, PhD Vice President of Biometrics at Arcutis Biotherapeutics, Inc; Richard C. Zink, PhD Principal Research Fellow at JMP Statistical Discovery LLC; Bernard Vrijens, PhD CEO and Scientific Lead at AARDEX Group
Mikael Hiligsmann, Doctor of Philosophy Maastricht University, Sean Lawley, Doctor of Philosophy University of Utah, Bernard Vriens, Doctor of Philosophy, AARDEX Group and University of Liège
Lina Eliasson, Sprout Health Solutions , Bernard Vrijens, AARDEX Group, and Thomas Podsadecki, Development and Regulatory Affairs
Rebecca Beck, BD, Bernard Vrijens, AARDEX Group, and Arnaud Guillet, Biocorp
Job Van Boven, Associate Professor, University Medical Center Groningen, and Bernard Vrijens, Scientific Lead, AARDEX Group
Matt Bolton of Merck and Ning Yu of Biogen
Ken Kaitin, TUFTS, John Musaus, Thermo Fisher and Timothy Peters-Strickland, PPD
WHERE TO FIND US NEXT
Our medication adherence experts are on a mission to change the game in clinical trials. They'll be taking our message to the people at several upcoming conferences. If you're ready to join the movement and revolutionize your approach to adherence in clinical trials, be sure to catch us at one of these events.
June 26-28, 2024, Tokyo, Japan
July 8, 2024, 6:30-8:30pm, Boston Mariott Burlington, USA
July 9-10, 2024, Boston, USA
August 30, 2024, Brussels, Belgium
November 10-13, 2024, Boston, USA
November 21-23, 2024, Naples, Italy
WHERE TO FIND US NEXT
Our medication adherence experts are on a mission to change the game in clinical trials. They'll be taking our message to the people at several upcoming conferences. If you're ready to join the movement and revolutionize your approach to adherence in clinical trials, be sure to catch us at one of these events.
January 21-22, 2026, Paris, France
February 18-20, 2026, Washington DC, USA
September 14-17, 2026, Birmingham, United Kingdom
October 13-16, 2026, Madrid, Spain
IN CONVERSATION WITH MERCK & BIOGEN
Mitigating the Risk of Poor Adherence in Trials
Watch this live recording with adherence experts from Merck & Biogen to learn about their approach to mitigating the risk of poor adherence in trials.
Aardex Grioup’s mission is to enhance medication adherence in clinical trials through cutting-edge technologies and innovative approaches.
If you are interested in learning more about our solutions, reach out to us to request information, samples, or schedule a demo.
FROM THE AARDEX GROUP BLOG
We are thrilled to feature expert insights from Bernard Vrijens, a world-renowned expert on medication adherence. Taking medication as prescribed is crucial to achieving optimal health outcomes, yet non-adherence is a prevalent issue. Bernard Vrijens' extensive research and experience in the field provide invaluable insights into the factors that contribute to medication non-adherence and effective strategies to address them. His contributions to our medication adherence blog offer actionable advice and evidence-based recommendations to improve medication adherence and ultimately, patient outcomes.
A few eyebrows were raised in earlier this year when Bristol Myers Squibb (BMS) announced the details of a noteworthy new partnership with investment firm Bain Capital. The agreement will see the creation of an entirely new, fully independent and
In a democratic society, elections are held up as powerful indicators of the will of the people. But, strictly speaking, that it is not the case. In fact, elections indicate the will of some of the people – namely, those
This August (2025), the U.S. Food & Drug Administration (FDA) set out draft guidance that could significantly impact the future of clinical trials focused on oncology treatments. Building on recent cross-industry discussions around endpoints, the 18 page document details several
So strong is the human allegiance to the status quo that it is rare for the momentum of change not to be accompanied by frictional forces of resistance. Rather than running towards new ways of working, our natural instinct typically
What Is Patient Adherence and Why It Matters According to the World Health Organization (WHO), “adherence to long-term therapies is the extent to which a person’s behavior, taking medication, following a diet, and executing lifestyle changes corresponds with agreed recommendations
Understanding the Practice-Protocol Paradox in Medication Adherence As humans, the unconscious act of making assumptions is inherent in our DNA. These mental shortcuts are deeply wired into our brains as a way of quickly making sense of the world around